Insulin glargine, recombinant Subcutaneous and Posaconazole Injection
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Posaconazole Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Posaconazole Intravenous
- Insulin glargine, recombinant Subcutaneous-Posaconazole Oral Suspension
- Insulin glargine, recombinant Subcutaneous-Posaconazole oral/injection
- Insulin glargine, recombinant Subcutaneous-Posaconazole Tablets
- Insulin glargine, recombinant Subcutaneous-PosiFlush flush
- Insulin glargine, recombinant Subcutaneous-Positive Skin Test Control - Histamine
- Posaconazole Injection-Insulin glulisine
- Posaconazole Injection-Insulin Glulisine (Cartridges and Pens)
- Posaconazole Injection-Insulin Glulisine (Vials)
- Posaconazole Injection-Insulin glulisine Subcutaneous
- Posaconazole Injection-Insulin human inhaled Inhalation
- Posaconazole Injection-Insulin human regular Injection